PMID: 6404869Mar 1, 1983Paper

Analysis of the severe complications of irradiation of carcinoma of the cervix: whole pelvis irradiation and intracavitary radium

International Journal of Radiation Oncology, Biology, Physics
A D HambergerG H Fletcher

Abstract

From January, 1967 to December, 1974, 325 patients with carcinoma of the uterine cervix were treated with a minimum of 4,000 rad whole pelvis irradiation plus intracavitary radium. These patients had large, sometimes massive, tumors. Generally, the larger the primary tumor the greater the amount of external irradiation delivered, with an appropriate reduction in the amount of intracavitary radium. Patients who had a positive lymphangiogram or a pre- or postirradiation hysterectomy or lymphadenectomy are not included in this analysis. All patients were followed for a minimum of 5 years. Local and regional failure rate in 193 patients receiving 4,000 rad whole pelvis irradiation plus radium was 1% and 4%, respectively, with a 3.1% incidence of severe complications. In 111 patients who received 5,000 rad whole pelvis irradiation plus radium, the local and regional failure rate was 3.5% and 4.5%, respectively, with a 10% incidence of severe complications. In patients who received 5,000 rad whole pelvis irradiation, complications were associated with unilateral parametrial boosts and with protruding vaginal sources. Of 21 patients who received 6,000 rad whole pelvis irradiation, three patients developed fistulae associated with high...Continue Reading

References

Jan 1, 1962·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·P M CHAUG D DODD

❮ Previous
Next ❯

Citations

Apr 1, 1986·World Journal of Surgery·J D CoxL E Olson
Apr 1, 1986·World Journal of Surgery·S J Mathes, D J Hurwitz
Aug 1, 1993·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Y M van KasterenP Kenemans
Jun 1, 1988·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C HaieJ F Heron
May 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J J FeldmeierR Alecu
Jul 1, 1987·International Journal of Radiation Oncology, Biology, Physics·H PourquierC Vrousos
Jan 1, 1989·International Journal of Radiation Oncology, Biology, Physics·G S Montana, W C Fowler
Feb 15, 1995·International Journal of Radiation Oncology, Biology, Physics·R KomakiG E Hanks
Jul 30, 1995·International Journal of Radiation Oncology, Biology, Physics·K TsujiR Nakano
Oct 1, 1996·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·E RosenblattA Kuten
Jun 25, 2003·Gynecologic Oncology·William IrvinBernard Schneider
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·A Katz, P J Eifel
Aug 3, 2001·International Journal of Radiation Oncology, Biology, Physics·R FerrignoJ V Salvajoli
Jan 15, 1997·International Journal of Radiation Oncology, Biology, Physics·J C RoeskeR R Weichselbaum
Jul 1, 1999·International Journal of Radiation Oncology, Biology, Physics·C A PerezJ Williamson
Aug 20, 2003·Clinical Oncology : a Journal of the Royal College of Radiologists·S SundarC Deehan
Oct 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J-Y ParkJ-H Nam
Nov 15, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Dong Hoon SuhSoon-Beom Kang
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·D FinkN F Hacker
Mar 16, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E A BarnesR Sankreacha
Jun 1, 1997·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·E Senkus-KonefkaA Badzio
Jun 1, 1990·International Journal of Radiation Oncology, Biology, Physics·R A Potish
Aug 1, 1987·International Journal of Radiation Oncology, Biology, Physics·B A EscheJ C Horiot
Apr 1, 1987·International Journal of Radiation Oncology, Biology, Physics·K KogaN Mori
May 1, 1988·International Journal of Radiation Oncology, Biology, Physics·R NathJ J Fischer
Jan 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P A VisserA H Keijser
Apr 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J M CrookJ C Horiot
Jan 1, 1988·Gynecologic Oncology·J A StrykerJ Shafer
Jan 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P SismondiM Giai
Apr 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·N J DalyM Delannes
Mar 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·G SinistreroP Zola
Jul 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K S KappA G Hackl
Mar 18, 2008·International Journal of Radiation Oncology, Biology, Physics·Richard E ClarkeMargaret B Walker
Mar 1, 1991·Clinical Oncology : a Journal of the Royal College of Radiologists·B JeremicL J Mijatovic
Jan 1, 1986·Cancer·G S MontanaL Shemanski
Oct 3, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Chrishanthi RajasooriyarKailash Narayan
Oct 9, 1998·Scandinavian Journal of Urology and Nephrology·M A MemonP M Neal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.